First Republic Investment Management, Inc. A Tyr Pharma Inc Transaction History

First Republic Investment Management, Inc.

$34.7 Billion
Q3 2023

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2020 Nov 12, 2020	SELL	$3.23 - $5.39 $72,930 - $121,700	-22,579 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$3.03 - $4.83 $68,414 - $109,056	22,579 New	22,579 $94,000

Others Institutions Holding LIFE

# of Institutions

Shares Held

38.4M

Call Options Held

200

Put Options Held

4.6K

Federated Hermes, Inc. Pittsburgh, PA

14.7M
Shares

$27.3 Million
0.06% of portfolio
Logos Global Management LP San Francisco, CA

3M
Shares

$5.58 Million
0.44% of portfolio
Vanguard Group Inc Valley Forge, PA

2.65M
Shares

$4.93 Million
0.0% of portfolio
Tikvah Management LLC Charlotte, NC

2.46M
Shares

$4.58 Million
1.27% of portfolio
Checkpoint Capital L.P. San Francisco, CA

1.95M
Shares

$3.62 Million
1.83% of portfolio

View Full List

About aTYR PHARMA INC

Ticker LIFE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,625,000
Market Cap $53.2M
Description
aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. The company's lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase II clinical trial for pulmonary sarcoidosis; and in Phase 1b/2a clinical trial for ...

More about LIFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Republic Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Republic Investment Management, Inc. with notifications on news.

Account